Your session is about to expire
← Back to Search
Other
Blood Flow Restriction (BFR) for Healthy Subjects
N/A
Recruiting
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 4,6,8,12 and 16 weeks.
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing how well a low-load exercise routine works at strengthening muscles compared to conventional methods.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at 4,6,8,12 and 16 weeks.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 4,6,8,12 and 16 weeks.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The change in Force plate measures from baseline to 16 weeks
the change in Force plate measures from baseline to 16 weeks
the changes in Force Frame measure from baseline to 16 weeks
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2 - Low-load BFR groupExperimental Treatment2 Interventions
Participants will warm up on a stationary bike for 5 minutes BFR will be applied to non-dominant limb (dominant limb is determined as the preferred leg for kicking a ball)
The program will consist of the following exercises using a 30,15,15,15 rep scheme:
Banded squats Step ups (8 inch) Romanian dead lifts (RDL)
Group II: Group 1 - Standard strengthening group (no BFR)Active Control1 Intervention
Participants will warm up on a stationary bike for 5 minutes
The program will consist of the following exercises using a 30,15,15,15 rep scheme:
Banded squats Step ups (8 inch) Romanian dead lifts (RDL)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BFR
2019
N/A
~30
Find a Location
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
511 Previous Clinical Trials
163,286 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Group 1 - Standard strengthening group (no BFR)
- Group 2: Group 2 - Low-load BFR group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Healthy Subjects Patient Testimony for trial: Trial Name: NCT05868304 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger